Investor Relations

We maintain a transparent, comprehensive dialogue with the financial community about our strategy, outlook, financial data, economic environment, and social impact.

Fourth quarter and full year 2023 results

Fourth quarter and full year 2023 results were reviewed by management during a live audio webcast with the financial community on February 1st, 2024. The presentation was followed by a Q&A session.

Upcoming events

25Apr

2024

First quarter 2024 results

First quarter 2024 results will be reviewed by management during a live audio webcast with the financial community on April 25th, 2024. The presentation will be followed by a Q&A session.

14:30 - 16:00 CET (8:30am – 10am EST)

Quarterly Results

Discover more

30Apr

2024

General Meeting 2024

The Sanofi General Meeting will be held on April 30, 2024 at 02:30pm (CET) in the “Blue Amphitheatre” at the Palais des Congrès in Paris, Porte Maillot.

For any questions relating to this event, you can contact us from Monday to Friday from 09:00am to 06:00pm (CET) from France (free call from a landline): +33 800 800 826.

14:30 - 16:30

Annual General Meeting (AGM)

Discover more

25Jul

2024

Second quarter 2024 results

Second quarter 2024 results will be reviewed by management during a live audio webcast with the financial community on July 25th, 2024. The presentation will be followed by a Q&A session.

14:30 - 16:00 CET (8:30am – 10am EST)

Quarterly Results

Discover more

Press releases

March 11, 2024
Press Release: New Phase 2b results for amlitelimab support potential for best-in-class maintenance of response in atopic dermatitis
February 24, 2024
Press Release: Phase 2 results demonstrate rilzabrutinib rapidly reduced itch severity and significantly improved disease activity in adults with chronic spontaneous urticaria
February 24, 2024
Media Update: Dupixent® continues scientific leadership with late-breaking results showing reduced airway inflammation and mucus plugging in adults with uncontrolled moderate-to-severe asthma
Dr. Lingaraju checks the health of Manikantan as his sister Geetha watches closely inside the Billigiri Ranganathaswamy Temple Tiger Reserve in Chamrajanagara district, Karnataka state, India
Dr. Lingaraju checks the health of Manikantan as his sister Geetha watches closely inside the Billigiri Ranganathaswamy Temple Tiger Reserve in Chamrajanagara district, Karnataka state, India

Environment, Social, Governance

As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.

Contact Our Investor Relations Team

To join the Sanofi front desk,

Please contact the Global Headquarters in France :
+33 (0)1 53 77 40 00

To contact the Investor Relations team:

46 avenue de la Grande Armée
75017 Paris FRANCE
investor.relations (at) sanofi.com